EP
HURA

Essential Partners’s TuHURA Biosciences HURA Stock Holding History

Essential Partners’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08K Sell
460
-3,250
-88% -$7.57K ﹤0.01% 2216
2026
Q1 		$6.64K Buy
3,710
+3,616
+3,847% +$4.43K ﹤0.01% 1452
2025
Q4 		$71 Sell
94
-355
-79% -$679 ﹤0.01% 2605
2025
Q3 		$1.11K Buy
+449
New +$1.18K ﹤0.01% 1992

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Essential Partners's HURA Position: Q2 2026 in Review

Essential Partners reduced its TuHURA Biosciences (HURA) stake by 88% in Q2 2026, selling an estimated $7.57K and leaving 460 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2216.

Essential Partners first reported a position in HURA in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.64K in Q1 2026. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Essential Partners held 460 shares of TuHURA Biosciences worth $1.08K as of Q2 2026.
  • Essential Partners sold 3,250 TuHURA Biosciences shares in Q2 2026, an estimated $7.57K.
  • TuHURA Biosciences made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2216 holding.
  • Essential Partners first reported a position in TuHURA Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Essential Partners's TuHURA Biosciences position peaked at $6.64K in Q1 2026.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.